Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
Titel:
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
Auteur:
Comi, Giancarlo Kappos, Ludwig Selmaj, Krzysztof W Bar-Or, Amit Arnold, Douglas L Steinman, Lawrence Hartung, Hans-Peter Montalban, Xavier Kubala Havrdová, Eva Cree, Bruce A C Sheffield, James K Minton, Neil Raghupathi, Kartik Ding, Ning Cohen, Jeffrey A